LEE Ventus’ Long Life Pump Exceeds 1 Trillion Cycles
LEE Ventus (formerly known as TTP Ventus), manufacturer of the Disc Pump range of award-winning micropumps, announces a milestone in durability testing of its LT Series Disc Pump. The product line, optimised for long service life, has now surpassed 17,000 hours’ operation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221031005024/en/
LEE Ventus’ long life pump exceeds 1 trillion cycles, surpassing 17,000+ running hours. This milestone result equates to two years’ continuous operation. (Graphic: Business Wire)
This extended service life means that LT Series pumps can serve ever more-demanding applications, with the pump able to support 2 years of continuous use.
Burag Yaglioglu, Reliability and Data Analytics Lead at LEE Ventus, commented: “During testing, pumps are driven in an elevated environmental temperature of 40 °C (104 °F) and against a restrictive load that limits the amount of airflow (and therefore cooling) through the pump. These conditions are intended to accelerate the wear processes to ensure that we put the pump through its paces.”
“In this test, the pumps ran at 0.6 W—or about 60% of their rated power—without significant change in their performance for 17,000 hours—as the pump operates 21,000 times per second, this equates to around 1.3 trillion cycles. We’ve been able to deliver this exceptional result through advancements in valve technology.”
Tom Harrison, Managing Director, added: “When we introduced the LT Series with a lifetime of 5,000 hours, we emphasised our commitment to driving further improvements over time. We are delighted to deliver on this ambition and to broaden the range of applications that can take advantage of the technology.”
LEE Ventus’ Disc Pump platform delivers exceptional pressure and flow, silent operation, millisecond-response time, precision controllability and pulsation-free flow. These features enable product designers to drive innovation, across applications from air quality monitoring through wearable medical devices.
LEE Ventus will be attending Compamed 2022, Hall 8A Booth H23. Please do come and visit us to discuss further.
You can also find out more about our LT Series and download accompanying datasheets here.
About LEE Ventus—www.ttpventus.com
LEE Ventus (formerly known as TTP Ventus) manufactures the Disc Pump range of award-winning micropumps. The pumps deliver high pressure and flow, silent operation, rapid response time, accuracy, infinite turn-down ratio and ultra-smooth flow – all in a tiny package, to support product innovations through wearability, portability, and simplicity.
Disc Pumps excite a high-frequency acoustic standing wave in a fixed-volume cavity. A patented ultra-fast valve technology rectifies this standing wave to deliver pumped flow.
LEE Ventus is based in Cambridge, UK and is focused on the manufacture and supply of the Disc Pump range. The company was recently acquired by The Lee Company (https://www.theleeco.com), a world leader in miniature precision fluid control products.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221031005024/en/
Contact information
Emma Wilson, LEE Ventus
Tel: +44 (0)1763 262626
Email: emma.wilson@ttpventus.com
To opt-out from receiving press releases from LEE Ventus, please email enquiries@ttpventus.com.
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Making Science Unveils ‘AWAKE’: The AI Venture Studio Industrialising Startup Creation and AI-First Innovative Solutions23.12.2025 20:51:00 CET | Press Release
Making Science, the global digital acceleration consultancy, today announced the launch of AWAKE Venture Studio. This "AI-first" model represents a new era in systematic innovation, designed to identify, prototype, and scale both internal proprietary solutions and independent AI-native startups with global reach. The launch of AWAKE is motivated by the significant efficiency gains of orders of magnitude that Making Science has already achieved through the internal integration of AI. By applying these methods, the firm has achieved a 2x acceleration in tech feature development reducing time in the deployment of AI Agents. This model has already proven its commercial and innovative power through the acceleration of startups like ad-machina, which has multiplied its value by 10 since joining the Making Science ecosystem. These proven benchmarks serve as the technical foundation for AWAKE’s two interconnected engines, which formalise this efficiency into a repeatable manufacturing process
FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia23.12.2025 18:07:00 CET | Press Release
The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia utilizing patented Extended Depth of Focus (EDOF) optical design technology, enabling commercial distribution in the United States. Deseyne® delivers smooth, continuous focus across near, intermediate, and distance vision, providing clear, natural vision without compromise. This performance is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner. The result is a clear clinical advantage over the only other available contact lens option for presbyopia, multifocal lenses, which rely on multiple optical zones and often require prolonged visual and cognitive adaptation. “We are proud to offer the first contact lens solution for the world’s aging population th
Aramco Awards SLB Long-Term Contract to Support Kingdom’s Unconventional Gas Production Growth23.12.2025 14:58:00 CET | Press Release
Global technology company SLB (NYSE: SLB) has been awarded a five-year contract by Aramco to provide stimulation services for its unconventional gas fields. This award is part of a broader multi-billion contract, supporting one of the largest unconventional gas development programs globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223074948/en/ The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources. The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources — a cornerstone of the Kingdom’s strategy to diversify its energy portfolio and support the global energy transition. “This agreement is an important step forward in Aramco’s effor
Tabelog, Japan's Largest (*1) Restaurant Search and Reservation Service, Launches Multilingual App for International Visitors23.12.2025 14:00:00 CET | Press Release
Tabelog (https://tabelog.com/en/), Japan's largest restaurant search and reservation service operated by Kakaku.com, Inc., launched its multilingual smartphone application (iOS/Android) for international travelers on Monday, November 17, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251221963753/en/ The Tabelog Multilingual App for International Travelers — Japan's Largest Restaurant Search and Reservation Service With approximately 100 million monthly users(*3), Tabelog is Japan's premier service widely used by Japanese locals for daily restaurant discovery. Its database is unrivaled domestically, featuring information on approximately 890,000 establishments nationwide and over 85 million reviews and photos(*4). Unlike global map services or travel sites, Tabelog is built on "authentic ratings and reviews from local Japanese users," enabling travelers to discover truly exceptional restaurants beloved by locals — not
BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference23.12.2025 12:01:00 CET | Press Release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST. Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company based in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom